skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Refined by: Database: MEDLINE remove Database: Taylor & Francis (Open access) remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Comparison of Bioavailability and Bioequivalence of Generic and Brand Name Formulations of Escitalopram Oxalate Tablets in Healthy Chinese Population Under Fasting and Fed Conditions
Material Type:
Article
Add to My Research

Comparison of Bioavailability and Bioequivalence of Generic and Brand Name Formulations of Escitalopram Oxalate Tablets in Healthy Chinese Population Under Fasting and Fed Conditions

Drug design, development and therapy, 2020-01, Vol.14, p.5167-5177 [Peer Reviewed Journal]

2020 Li et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Li et al. 2020 Li et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S271970 ;PMID: 33262577

Full text available

2
Comparative Bleeding Risk of Brand Vs Generic Rivaroxaban in Elderly Inpatients with Atrial Fibrillation
Material Type:
Article
Add to My Research

Comparative Bleeding Risk of Brand Vs Generic Rivaroxaban in Elderly Inpatients with Atrial Fibrillation

Drug design, development and therapy, 2024-01, Vol.18, p.1573-1582 [Peer Reviewed Journal]

2024 Chen et al. ;2024 Chen et al. 2024 Chen et al. ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S459658 ;PMID: 38765878

Full text available

3
Bioequivalence Evaluation of Two Formulations of Tenofovir Alafenamide Tablets in Healthy Subjects Under Fasting and Fed Conditions
Material Type:
Article
Add to My Research

Bioequivalence Evaluation of Two Formulations of Tenofovir Alafenamide Tablets in Healthy Subjects Under Fasting and Fed Conditions

Drug design, development and therapy, 2021-01, Vol.15, p.2551-2562 [Peer Reviewed Journal]

2021 Li et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Li et al. 2021 Li et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S304108 ;PMID: 34163141

Full text available

4
In vitro comparative quality assessment of different brands of norfloxacin tablets available in Jimma, Southwest Ethiopia
Material Type:
Article
Add to My Research

In vitro comparative quality assessment of different brands of norfloxacin tablets available in Jimma, Southwest Ethiopia

Drug design, development and therapy, 2019-01, Vol.13, p.1241-1249 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Hambisa et al. This work is published and licensed by Dove Medical Press Limited 2019 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S189524 ;PMID: 31118565

Full text available

5
In vitro Comparative Quality Assessment of Different Brands of Furosemide Tablets Marketed in Northwest Ethiopia
Material Type:
Article
Add to My Research

In vitro Comparative Quality Assessment of Different Brands of Furosemide Tablets Marketed in Northwest Ethiopia

Drug design, development and therapy, 2020-01, Vol.14, p.5119-5128 [Peer Reviewed Journal]

2020 Abebe et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Abebe et al. 2020 Abebe et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S280203 ;PMID: 33262573

Full text available

6
Generic Tacrolimus (Tacrobell ® ) Shows Comparable Outcomes to Brand-Name Tacrolimus in the Long-Term Period After Adult Deceased Donor Liver Transplantation
Material Type:
Article
Add to My Research

Generic Tacrolimus (Tacrobell ® ) Shows Comparable Outcomes to Brand-Name Tacrolimus in the Long-Term Period After Adult Deceased Donor Liver Transplantation

Drug design, development and therapy, 2019-12, Vol.13, p.4431-4438 [Peer Reviewed Journal]

2019 Kim et al. ;COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Kim et al. 2019 Kim et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S229114 ;PMID: 32021085

Full text available

7
Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives
Material Type:
Article
Add to My Research

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives

Vascular health and risk management, 2019-01, Vol.15, p.571-579 [Peer Reviewed Journal]

2019 Manolis et al. ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Manolis et al. 2019 Manolis et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S210150 ;PMID: 31920323

Full text available

8
Secukinumab for rheumatology: development and its potential place in therapy
Material Type:
Article
Add to My Research

Secukinumab for rheumatology: development and its potential place in therapy

Drug design, development and therapy, 2016-01, Vol.10, p.2069-2080 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Koenders and van den Berg. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S105263 ;PMID: 27445458

Full text available

9
Switching treatments in COPD: implications for costs and treatment adherence
Material Type:
Article
Add to My Research

Switching treatments in COPD: implications for costs and treatment adherence

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10, p.2601-2608 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Braido et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S79635 ;PMID: 26664108

Full text available

10
Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
Material Type:
Article
Add to My Research

Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation

Drug design, development and therapy, 2014-01, Vol.8 (default), p.2401-2408 [Peer Reviewed Journal]

COPYRIGHT 2014 Dove Medical Press Limited ;COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Ochi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S71419 ;PMID: 25584019

Full text available

11
Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
Material Type:
Article
Add to My Research

Safety of switching from brand-name to generic levetiracetam in patients with epilepsy

Drug design, development and therapy, 2017-01, Vol.11, p.2287-2291 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Bosak et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S138270 ;PMID: 28814836

Full text available

12
A mixed methods study of Canadian adolescents' perceptions of health
Material Type:
Article
Add to My Research

A mixed methods study of Canadian adolescents' perceptions of health

International journal of qualitative studies on health and well-being, 2016-01, Vol.11 (1), p.32891-12 [Peer Reviewed Journal]

2016 V. Michaelson et al. 2016 ;Copyright Taylor & Francis Ltd. 2016 ;ISSN: 1748-2631 ;ISSN: 1748-2623 ;EISSN: 1748-2631 ;DOI: 10.3402/qhw.v11.32891 ;PMID: 27741955

Full text available

13
Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
Material Type:
Article
Add to My Research

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10, p.2347-2356 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Ramadan et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S88246 ;PMID: 26586940

Full text available

14
The Effects of Varying Electronic Cigarette Warning Label Design Features On Attention, Recall, and Product Perceptions Among Young Adults
Material Type:
Article
Add to My Research

The Effects of Varying Electronic Cigarette Warning Label Design Features On Attention, Recall, and Product Perceptions Among Young Adults

Health communication, 2019-02, Vol.34 (3), p.317-324 [Peer Reviewed Journal]

2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group ;ISSN: 1041-0236 ;EISSN: 1532-7027 ;DOI: 10.1080/10410236.2017.1372050

Digital Resources/Online E-Resources

15
Pricing the Priceless Surgery: Professional Expertise and the Marketing of High-Risk Surgery in South Korea
Material Type:
Article
Add to My Research

Pricing the Priceless Surgery: Professional Expertise and the Marketing of High-Risk Surgery in South Korea

Medical anthropology, 2023-07, Vol.42 (5), p.465-478 [Peer Reviewed Journal]

2023 The Author(s). Published with license by Taylor & Francis Group, LLC. 2023 ;ISSN: 0145-9740 ;EISSN: 1545-5882 ;DOI: 10.1080/01459740.2023.2203392

Digital Resources/Online E-Resources

16
Effects of Varying Color, Imagery, and Text of Cigarette Package Warning Labels among Socioeconomically Disadvantaged Middle School Youth and Adult Smokers
Material Type:
Article
Add to My Research

Effects of Varying Color, Imagery, and Text of Cigarette Package Warning Labels among Socioeconomically Disadvantaged Middle School Youth and Adult Smokers

Health communication, 2019-02, Vol.34 (3), p.306-316 [Peer Reviewed Journal]

2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2017 ;ISSN: 1041-0236 ;EISSN: 1532-7027 ;DOI: 10.1080/10410236.2017.1407228

Digital Resources/Online E-Resources

17
Project Last Mile and the development of the Girl Champ brand in eSwatini: engaging the private sector to promote uptake of health services among adolescent girls and young women
Material Type:
Article
Add to My Research

Project Last Mile and the development of the Girl Champ brand in eSwatini: engaging the private sector to promote uptake of health services among adolescent girls and young women

SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance, 2021, Vol.18 (1), p.52-63 [Peer Reviewed Journal]

2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 The Author(s) ;ISSN: 1729-0376 ;EISSN: 1813-4424 ;DOI: 10.1080/17290376.2021.1894224 ;PMID: 33685358

Full text available

18
The China National Tobacco Corporation: From domestic to global dragon?
Material Type:
Article
Add to My Research

The China National Tobacco Corporation: From domestic to global dragon?

Global public health, 2017-03, Vol.12 (3), p.315-334 [Peer Reviewed Journal]

2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2016 ;ISSN: 1744-1692 ;EISSN: 1744-1706 ;DOI: 10.1080/17441692.2016.1241293

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2015  (2)
  2. 2015 To 2016  (4)
  3. 2017 To 2019  (7)
  4. 2020 To 2023  (5)
  5. After 2023  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait